Coley Pharmaceutical Group, Inc.
SEC CIK 1319197 · COLY · last insider filing 2008-01-31
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bate Kenneth | Director | filed 2006 - 2008 |
| Hugin Robert J | Director | filed 2006 - 2008 |
| Karobath Manfred E | Director | filed 2006 - 2008 |
| Langlois Patrick | Director | filed 2006 - 2008 |
| Bratzler Robert L | Director · President and CEO | filed 2007 - 2008 |
| Thomas James E | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Abdalian Charles H Jr | SVP, Finance and CFO | filed 2007 - 2008 |
| Krieg Arthur M | SVP, R&D, Chief Scientific Off | filed 2006 - 2008 |
| Massari Ferdinand E | Sr. VP of Drug Development | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.